Intra-individual comparison of p-[123I]-iodo-L-phenylalanine and L-3-[123I]-iodo-α-methyl-tyrosine for SPECT imaging of gliomas

No abstract is available for this paper.

• Publication year

  2007

• Venue

  European Journal of Nuclear Medicine and Molecular Imaging

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00259-007-0514-2PMID 17846769
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• EANM procedure guidelines for brain tumour imaging using labelled amino acid analogues

  2006cited by this paper
• Image reconstruction

  2006cited by this paper
• Automated nuclear segmentation in the determination of the Ki-67 labeling index in meningiomas.

  2006cited by this paper
• O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas.

  2005cited by this paper
• Validation of brain tumour imaging with p-[123I]iodo-l-phenylalanine and SPECT

  2005cited by this paper
• Action and efficacy of p-[131I]iodo-L-phenylalanine on primary human glioma cell cultures and rats with C6-gliomas.

  2004cited by this paper
• Image Reconstruction

  2004cited by this paper
• 123I-IMT SPECT and 1HMR-Spectroscopy at 3.0T in the Differential Diagnosis of Recurrent or Residual Gliomas: A Comparative Study

  2004cited by this paper
• Imaging gliomas with positron emission tomography and single-photon emission computed tomography.

  2003cited by this paper
• Noninvasive grading of untreated gliomas: a comparative study of MR imaging and 3-(iodine 123)-L-alpha-methyltyrosine SPECT.

  2002cited by this paper
• Implications of IMT-SPECT for postoperative radiotherapy planning in patients with gliomas.

  2002cited by this paper
• Initial evaluation of the feasibility of single photon emission tomography with p-[123I]iodo-L-phenylalanine for routine brain tumour imaging

  2002cited by this paper
• Clinical value of iodine-123-alpha-methyl-L-tyrosine single-photon emission tomography in the differential diagnosis of recurrent brain tumor in patients pretreated for glioma at follow-up.

  2002cited by this paper
• Validation of a method for automatic image fusion of CT-data and C11-methionin-PET data for stereotactic radiotherapy using a LINAC (BrainLAB System). First clinical results

  2002cited by this paper
• Correlation between postoperative 3-[(123)I]iodo-L-alpha-methyltyrosine uptake and survival in patients with gliomas.

  2001cited by this paper
• Preparation and investigation of tumor affinity, uptake kinetic and transport mechanism of iodine-123-labelled amino acid derivatives in human pancreatic carcinoma and glioblastoma cells.

  2001cited by this paper
• Correlation Between Postoperative 3-[123I]Iodo-l-α-Methyltyrosine Uptake and Survival in Patients with Gliomas

  2001cited by this paper
• Sequential scintigraphic strategy for the differentiation of brain tumours

  2000cited by this paper
• Improved efficiency for MRI-SPET registration based on mutual information

  2000influential reference
• Investigation of iodine-123-labelled amino acid derivatives for imaging cerebral gliomas: uptake in human glioma cells and evaluation in stereotactically implanted C6 glioma rats

  2000cited by this paper
• O-(2-[18F]Fluoroethyl)-l-tyrosine and l-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study

  2000cited by this paper
• Evaluation of l-3-[123I]iodo-α-methyltyrosine SPET and [18F]fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: a comparative study with stereotactic biopsy

  1999cited by this paper
• Diagnosis of recurrent glioma with SPECT and iodine-123-α-methyl tyrosine

  1998cited by this paper
• Diagnosis of recurrent glioma with SPECT and iodine-123-alpha-methyl tyrosine.

  1998cited by this paper
• Iodine-123 α-methyl tyrosine single-photon emission tomography of cerebral gliomas: standardised evaluation of tumour uptake and extent

  1998cited by this paper
• Iodine-123-alpha-methyl tyrosine in gliomas: correlation with cellular density and proliferative activity.

  1997cited by this paper
• Whole-body kinetics and dosimetry of L-3--123I-iodo-alpha-methyltyrosine.

  1997cited by this paper
• Non-invasive grading of primary brain tumours: Results of a comparative study between SPET with123I-α-methyl tyrosine and PET with18F-deoxyglucose

  1997cited by this paper
• Multimodality image registration by maximization of mutual information

  1997cited by this paper
• Whole-body kinetics and dosimetry ofl-3-[123I]iodo-α-methyltyrosine

  1997cited by this paper
• Uptake of iodine-123-alpha-methyl tyrosine by gliomas and non-neoplastic brain lesions.

  1996cited by this paper
• Uptake of iodine-123-α-methyl tyrosine by gliomas and non-neoplastic brain lesions

  1996cited by this paper
• Accelerated image reconstruction using ordered subsets of projection data

  1994cited by this paper
• SPECT studies of brain tumors with L-3-[123I] iodo-alpha-methyl tyrosine: comparison with PET, 124IMT and first clinical results.

  1990cited by this paper
• A general algorithm for oblique image reconstruction

  1990cited by this paper
• Imaging of brain tumors with L-3-[123I]iodo-alpha-methyl tyrosine and SPECT.

  1989cited by this paper
• Imaging of Brain Tumors with L-3-[123I]Iodo-α-Methyl Tyrosine and SPECT

  1989cited by this paper
• Attenuation Correction and Incomplete Projection in Single Photon Emission Computed Tomography

  1979cited by this paper
• A Method for Attenuation Correction in Radionuclide Computed Tomography

  1978cited by this paper

• Leveraging Cancer Metabolism to Translate into Effective Therapeutics.

  2025cites this paper
• Neopentyl glycol-based radiohalogen-labeled amino acid derivatives for cancer radiotheranostics

  2024cites this paper
• A perspective on the radiopharmaceutical requirements for imaging and therapy of glioblastoma

  2021cites this paper
• Single-Photon Emission Computed Tomography [Neuro-SPECT] Imaging of Brain Tumors

  2020cites this paper
• The prognostic value of [123I]-vascular endothelial growth factor ([123I]-VEGF) in glioma

  2018cites this paper
• Explorative analysis of IPA‐SPECT data through statistical inference for an automated diagnosis of glioma tumor

  2018cites this paper
• Biological evaluation of new [(18) F]F-labeled synthetic amino acid derivatives as oncologic radiotracers.

  2016cites this paper
• Synthesis and Biological Evaluation of (S)-Amino-2-methyl-4-[(76)Br]bromo-3-(E)-butenoic Acid (BrVAIB) for Brain Tumor Imaging.

  2015cites this paper
• Advances in Radiotracer Development for Molecular Imaging

  2014cites this paper
• PET imaging to monitor cancer therapy.

  2014cites this paper
• Radiosynthesis and biological evaluation of alpha-[F-18]fluoromethyl phenylalanine for brain tumor imaging.

  2013cites this paper
• Progress on the diagnosis and evaluation of brain tumors

  2013cites this paper
• Iodoreboxetine : the development of a novel SPECT brain imaging tracer for the noradrenaline transporter

  2013cites this paper
• Scintigraphy for Brain Tumors

  2011cites this paper
• Validation of an amino-acid-based radionuclide therapy plus external beam radiotherapy in heterotopic glioblastoma models.

  2011cites this paper
• An alternative and expedient synthesis of radioiodinated 4-iodophenylalanine.

  2011cites this paper
• Neuro-Oncology Single-Photon Emission CT: A Current Overview

  2011cites this paper
• Brain Tumor Imaging Using p-[123I]Iodo-L-Phenylalanine and SPECT

  2011cites this paper
• The role of scintigraphy in the evaluation of brain malignancies.

  2010cites this paper
• Prospective study of p-[123I]iodo-L-phenylalanine and SPECT for the evaluation of newly diagnosed cerebral lesions: specific confirmation of glioma

  2010cites this paper
• Nuklearmedizinische Diagnostik in der Neuroonkologie

  2009cites this paper
• Tumor Cell Metabolism Imaging

  2008cites this paper
• Improved synthesis of no-carrier-added p-[124I]iodo-L-phenylalanine and p-[131I]iodo-L-phenylalanine for nuclear medicine applications in malignant gliomas.

  2008cites this paper
• Current awareness in contrast media and molecular imaging.

  2008cites this paper
• PET imaging with p-[I-124]iodo-l-phenylalanine as a new tool for diagnosis and postoperative control in patients with glioma.

  2008cites this paper